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INTRODUCTION
When skin cancer is clinically suspected, biopsy is usually per-
formed preoperatively for histopathological diagnostic confirma-
tion. Then, according to the results of the biopsy, it is decided 
whether further surgery is necessary. When a skin lesion is highly 
suspected of malignancy upon physical examination by a surgeon 
or a dermatologist, full excision followed by a frozen biopsy is 
sometimes performed. If the results of the frozen biopsy show 
malignancy, a further wide excision is performed directly for 
complete excision. 
In the case of malignant melanoma, studies have been per-
formed for decades to determine whether cutting into a malig-
nant melanoma, a so-called preoperative biopsy, leads to a worse 
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Background  Skin cancer  is the most common malignant tumor  in humans. Basal cell 
carcinoma (BCC) and squamous cell carcinoma (SCC) are the two most common types of skin 
cancers. When skin cancer is clinically suspected, preoperative biopsies are recommended for 
a definite diagnosis. However, despite a concern over potential increased risk of metastasis 
associated with mechanical manipulation, there have been few investigations into whether a 
preoperative biopsy affected the recurrence of BCC and SCC. 
Methods  Primary BCC or SCC patients who underwent standard surgical excision from 1991 
to 2010 were reviewed and a retrospective analysis was performed. Ultimately, 45 BCC patients 
and 54 SCC patients, who did not meet the exclusion criteria, were analyzed. To identify 
whether a preoperative biopsy affected the recurrence of BCC and SCC, the recurrence rates 
of each with and without biopsy were compared. 
Results  Preoperative biopsy had no statistically significant effect on recurrence (BCC, 
P=0.8680; SCC, P=0.7520). Also, there was no statistical significance between the interval 
from initial biopsy to first operation and recurrence (BCC, P=0.2329; SCC, P=0.7140). Even 
though there was no statistical significance, the mean interval from the biopsy to the operation 
among the BCC patients who underwent preoperative biopsy was 9.2 months in those who had 
recurrence and 2.0 months in those who had no recurrence. 
Conclusions  There was no statistically significant relationship between preoperative biopsy 
and recurrence of BCC and SCC. However, there was a tendency toward recurrence in patients 
with a longer interval between the biopsy and the corrective operation in BCC. 
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prognosis for the patient, but it is still an object of controversy 
[1]. However, there are no reports about the effects of preop-
erative biopsy on recurrence of basal cell carcinoma (BCC) or 
squamous cell carcinoma (SCC). The aim of this study is to 
evaluate whether preoperative biopsies of BCC or SCC had af-
fected recurrence after operation. 
METHODS
Patients and methods
Primary BCC or SCC patients who underwent standard surgi-
cal excision with hospitalization between 1991 and 2010 were 
retrospectively reviewed. We collected information including 
age, sex, tumor location, size in maximal dimension, and time 
interval from preoperative biopsy to first operation. Preopera-
tive biopsies included excisional biopsy, incisional biopsy, and 
punch biopsy. 
Among the 102 BCC patients and 127 SCC patients, the pa-
tients who met the exclusion criteria were excluded, and 45 BCC 
patients and 54 SCC patients were ultimately analyzed. The 
exclusion criteria included recurrent cases, absence of distinct 
information about biopsy, follow-up duration of less than one 
month, and post-operative follow-up loss. 
The mean age of the BCC patients was 60 years old (range, 35 
to 85 years old) and that of the SCC patients was 63 years old 
(range, 30 to 94 years old). The female-to-male ratio was about 
1.37:1 among the cases of BCC and 0.8:1 among the cases of 
SCC. The average tumor size in maximal dimension was 1.3 cm 
in the BCC patients (range, 0.1 to 8.5 cm) and 2.6 cm in the 
SCC patients (range, 0.2 to 14.5 cm). The most common site of 
BCC was the midface, especially the nose, and that of SCC was 
the lower face, especially the cheek. The preoperative biopsy 
rate was 80.0% among the BCC patients and 90.8% among the 
SCC patients. The definition of “follow-up period” is from the 
operation day to the last visit. The mean follow-up period was 
5 years and 5 months in the BCC patients (range, 2.5 months 
to 15 years) and 4 years 1 month in the SCC patients (range, 3 
months to 11 years 8 months) (Table 1).
To prove the effect of preoperative biopsy on recurrence of 
BCC and SCC, the recurrence rates of BCC or SCC with and 
without biopsy were compared, respectively, using a logistic 
Table 1. Demographic data of patients
 Data Basal cell  carcinoma (%)
Squamous cell 
carcinoma (%)
 No. of patients 45 54
 Age (yr), mean (range)   60 (35-85)   63 (30-94)
 Sex
    Female
    Male
  
26 (57.8)
19 (42.2)
  
24 (44.4)
30 (55.6)
 Size of tumor (cm)
    >2
    <2
 
  8 (17.8)
37 (82.2)
 
30 (55.6)
24 (44.4)
 Average 1.3 2.6
 Site (head & neck)
    Scalp
    Upper face (forehead-eyebrow)
    Midface (eyelid-nose)
    Lower face (upper lip-chin)
    Ear & postauricular area
    Neck
 
2 (4.4)
2 (4.4)
27 (60.0)
13 (28.9)
1 (2.2)
0 (0.0)
 
  8 (14.8)
1 (1.9)
17 (29.6)
22 (40.7)
5 (9.3)
1 (1.9)
 Preoperative biopsy (+) 36 (80.0) 49 (90.8)
 Follow-up period, mean (range) 5 yr 4.9 mo  
(2.5 mo-15 yr)
4 yr 1.4 mo 
(3.4 mo-17 yr 6 mo)
Table 2. Information on patient groups with or without biopsy and recurrence 
 Data
Basal cell carcinoma Squamous cell carcinoma
Biopsy (+) Biopsy (-) Biopsy (+) Biopsy (-)
Total R (-) R (+) Total R (-) R (+) Total R (-) R (+) Total R (-) R (+)
 No. of patient (%)     36     33 3 (8.3) 9 8 1 (11.1)     49     39 10 (20.4) 5 5 0 (0.0)
 Age (yr), mean 60 60 63 61 62 57 63 60 70 65 65 -
 Size of tumor (cm) 
    >2  
    <2  
 
7
29
 
6
27
 
1
2
 
1
8
 
1
7
 
0
1
 
28
21
 
22
17
 
6
4
 
2
3
 
2
3
 
0
0
 Average (cm) 1.4 1.2 3.9 2.3 2.4 1.5 2.8 2.6 3.8 1.7 1.7
 Site (head & neck)
    Scalp
    Upper face
    Mid face
    Lower face
    Ear & postauricular area
    Neck
1
2
23
9
1
0
 
1
2
22
8
0
0
  
  
  
1
1
1
 
  
1
0
4
4
0
0
  
1
0
4
3
0
0
  
  
  
 
1
 
  
  
7
1
15
20
5
1
  
7
1
10
16
5
0
 
 
 
 
4
  
1
 
1
0
2
2
0
0
 
1
0
2
2
0
0
 
 Interval from biopsy to 
    operation (mo)
2.7 2.0 9.2 1.2 1.2 0.9
 R, recurrence. 
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regression analysis, controlling for confounding factors includ-
ing age, sex, and tumor size [2]. Furthermore, to confirm the 
relationship between the interval from biopsy to operation and 
postoperative recurrence, a logistic regression analysis was per-
formed among the biopsy groups. The data were analyzed using 
the SAS ver. 9.1.3 (SAS Institute Inc., Cary, NC, USA) statistics 
program. 
RESULTS
The composition of the groups is summarized in Table 2, which 
were divided according to whether or not diagnostic biopsy was 
performed preoperatively. There was no significant difference in 
terms of confounding factors including age, sex, or tumor size 
between the two groups. Each group was subdivided by tumor 
size above (high risk) and below 2 cm (low risk), and statistical 
analysis was performed. There was no statistically significant 
difference in the proportion of high risk cases between the two 
groups, which means that the compositions of each group in 
terms of severity had little difference. 
Among the cases of BCC, the recurrence rates with and with-
out biopsy were 8.3% (n=3) and 11.1% (n=1), respectively. 
The recurrence rates of SCC with and without biopsy were 
20.4% (n=10) and 0.0% (n=0), respectively. For cases with 
biopsy performed compared to non-biopsy cases, the odds ratio 
of recurrence was evaluated. There was no statistically significant 
association between preoperative biopsy and recurrence (Table 
3). The mean interval from biopsy to operation was 9.2 months 
(range, 20 days to 2years) among the BCC patients who had re-
currence, whereas that of those who had no recurrence was just 
2.0 months (range, 6 days to 6 years), which was much shorter 
than the recurrence group. In the group with SCC who under-
went biopsy, the mean interval from biopsy to operation was 
0.9 months (range, 14 days to 5 years) among the SCC patients 
who had recurrence, whereas that of those who had no recur-
rence was 1.2 months (range, 11 days to 10 months). The inter-
val from biopsy to operation had no statistically significant as-
sociation with recurrence (BCC, P=0.2329; SCC, P=0.7140) 
(Table 3). Among the BCC group members, the average tumor 
size was 1.2 cm in the patients without recurrence and 3.3 cm 
in the recurrence patients. Among the SCC group members, 
the average tumor size was 2.5 cm in the patients without recur-
rence and 3.8 cm in the recurrence patients. To clarify whether 
tumor size independently affected the recurrence of BCC or 
SCC, we performed a statistical analysis using a t-test, but there 
was no significant relationship between size and recurrence 
(BCC, P=0.3516; SCC, P=0.3435).   
DISCUSSION
Skin cancer is the most common malignant tumor in humans. 
BCC and SCC are the two most common types of skin cancers. 
Exposure to ultraviolet radiation is generally accepted as the ma-
jor cause of skin cancer, so it occurs most frequently in the head 
and neck region that is exposed directly to the sun [3].
Basal cell carcinoma is usually a slow-growing and locally inva-
sive tumor that rarely metastasizes, although its characteristics 
depend on histological variants. The risk factors associated with 
extensive subclinical spread include a tumor diameter greater 
than 2 cm, location on the central part of the face or ears, long-
standing duration, incomplete excision, an aggressive histologi-
cal pattern of growth, and perineural or perivascular involve-
ment [3,4].
Squamous-cell carcinoma in situ may progress to invasive dis-
ease if it is not completely removed [5]. Most invasive squamous 
cell carcinomas occur on the head and neck area. The represen-
tative risk factors for recurrence and metastasis of squamous cell 
carcinoma are size and location of the tumor, specifically the lip, 
ear, and scalp area [6].
There are two main reasons why incisional biopsy is performed 
preoperatively rather than by directly excising the tumor. First, 
curative surgery of skin cancer requires a wider excision margin, 
so it can be aesthetically hazardous. Second, in cases with low 
suspicion of malignancy, it is unnecessary to directly excise the 
tumor [7]. Therefore, preoperative biopsy of a skin tumor of the 
head and neck has become generally accepted. Following this 
practice, the majority of patients at our institute underwent pre-
operative biopsies (BCC, 80.0%; SCC, 90.7%). 
However, some reports of the negative effects of mechanical 
manipulation have been published [8,9]. Whatever the type of 
biopsy, cutting the tumor itself entails the possibility of seed-
ing malignant cells and can induce metastasis. Austin et al. re-
ported that cutting into a cutaneous melanoma could seed cells 
directly into the bloodstream, leading to a higher risk for distant 
Table 3. Factors associated with recurrence
 Groups Odds ratio (95%  confidence interval) P-value
 Biopsy performed preoperatively  
   (patients)
    BCC
    SCC 
  
  
1.270 (0.075-21.386)
1.484 (0.167-infinity)
  
  
0.8680 
0.7520 
 Average of interval from biopsy to  
  operation (mo)
    BCC
    SCC
  
  
1.006 (0.996-1.016)
1.002 (0.990-1.015)
  
  
0.2329 
0.7140 
 BCC, basal cell carcinoma; SCC, squamous cell carcinoma.
 Statistical significance for P<0.05.
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metastases and worse overall survival in the biopsy group [8]. 
Many studies have been performed over the past few decades to 
determine whether cutting into a malignant melanoma leads to 
a worse prognosis for the patient, but this is still an object of con-
troversy [1]. In this study, preoperative biopsy did not show any 
statistical significance for the recurrence of BCC or SCC. 
BCC metastasis via the lymphatics or blood is known to be 
extremely rare. The recurrence rate of BCC after definite surgi-
cal excision is known to range from 0.0028% to 0.55% [3]. In 
this study, the recurrence rates of BCC with and without biopsy 
were 8.3% and 11.1%, respectively, which are much higher than 
the established values. Many of the patients were referred to our 
hospital after being diagnosed by biopsy at other institutes or 
clinics, and our hospital is a tertiary center belonging to a medi-
cal institute. Thus, there might be a higher incidence of severe 
cases than at average hospitals. In the cases of BCC, the average 
interval from biopsy to operation in the recurrence group was 
9.2 months, which was much longer than that in the group with 
no recurrence (2.0 months). Even though there was no statisti-
cal significance, this shows the tendency towards recurrence of 
BCC with longer delays. If more patient data were collected, this 
could be clarified. However, this tendency suggests that definite 
surgical excision should be performed as soon as possible after 
biopsy.  
Regarding the SCC, the recurrence rate of the biopsy group 
was 20.4%; however, there was no recurrence among the pa-
tients who had direct definite surgery. In other words, there was 
no recurrence in those with SCC who did not have preoperative 
biopsy. Even though the number of patients without biopsy 
was only 5, this result can suggest some possibility of a nega-
tive effect of biopsy in SCC. However, there was no statistical 
significance; because the number of patients in the SCC group 
without biopsy was “zero,” there were limitations to the reliabil-
ity of the statistical analysis. Certainly, more patient data should 
be acquired and analyzed for statistical confirmation. The chief 
risk factors for SCC recurrence are known to be the size (>2 cm 
in diameter) and location of the tumor. However, in our results, 
there was no statistically significant relationship between size 
and recurrence, which means there could be complex factors 
besides tumor size that affect recurrence. 
There are several concerns that limit our ability to generalize 
these results. The main limitation is the small number of patients 
who did not undergo a preoperative biopsy because we only 
included patients who had reliable medical records. In light of 
these results, authors recommend the definite surgery of skin 
cancer as soon as possible after clinical or pathological diagnosis. 
Preoperative biopsy of skin cancer did not show a statistically 
significant influence on recurrence of BCC or SCC. However, 
in the cases of BCC, there was a tendency toward recurrence 
among those with a longer interval from biopsy to operation. 
This result supports definite treatment as early as possible after 
the preoperative biopsy for patients’ safety. There were no haz-
ardous relation between preoperative biopsy and recurrence 
of SCC and BCC, statistically. However, once the diagnosis is 
confirmed clinically or pathologically, definite surgery is recom-
mended as soon as possible. 
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